Peripheral Nerve Stimulators (PNS)–Pipeline Insight and Competitive Landscape, 2022
This report can be delivered to the clients within 4-5 Business Days
DelveInsight’s, “Peripheral Nerve Stimulators (PNS)–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Peripheral Nerve Stimulators (PNS) pipeline landscape. With the growing geriatric population around the world serving as a key driver for the prevalence of neurodegenerative diseases such as Alzheimer's and dementia, this number is expected to rise over the coming years. Growing knowledge of neurodegenerative disorders over the projected timeframe is also expected to be a key factor for the peripheral nerve stimulation industry. The market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. This report provides a detailed study of the emerging Peripheral Nerve Stimulators (PNS) devices along with competitive landscape to help better understand the emerging Peripheral Nerve Stimulators (PNS) devices.
Geography Covered
Peripheral Nerve Stimulators (PNS): Understanding
In most developed nations, neuropathic pain is a widespread health condition and affects about 40-60% of the geriatric population and adults around the world. For the treatment of many diseases and indications, such as complex regional pain syndrome, low back pain, neck pain and debilitating nerve injuries, the peripheral nerve stimulator is used as a peripheral nerve stimulator, and its growing prevalence is expected to fuel demand and the development of the peripheral nerve stimulator industry.
Peripheral nerve stimulators comprise a small electrical device that is surgically placed next to one of the peripheral nerves. The stimulation provided by this electrical device is recognized as a reliable way of treating chronic pain. Peripheral nerve stimulation devices are especially used in neurological diseases such as epilepsy, Alzheimer’s, Parkinson’s, and others.
Peripheral Nerve Stimulators (PNS) Devices Competitive Assessment
This segment of the Peripheral Nerve Stimulators (PNS) report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
Further product details are provided in the report……..
Peripheral Nerve Stimulators (PNS) Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
This segment of the report provides a detailed list of any commercial activity in the field of Peripheral Nerve Stimulators (PNS) devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
Peripheral Nerve Stimulators (PNS): Reimbursement
Further information is provided in the report……..
Report Highlights
DelveInsight’s, “Peripheral Nerve Stimulators (PNS)–Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Peripheral Nerve Stimulators (PNS) pipeline landscape. With the growing geriatric population around the world serving as a key driver for the prevalence of neurodegenerative diseases such as Alzheimer's and dementia, this number is expected to rise over the coming years. Growing knowledge of neurodegenerative disorders over the projected timeframe is also expected to be a key factor for the peripheral nerve stimulation industry. The market is expected to witness a profitable growth owing to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors. This report provides a detailed study of the emerging Peripheral Nerve Stimulators (PNS) devices along with competitive landscape to help better understand the emerging Peripheral Nerve Stimulators (PNS) devices.
Geography Covered
- Global coverage
Peripheral Nerve Stimulators (PNS): Understanding
In most developed nations, neuropathic pain is a widespread health condition and affects about 40-60% of the geriatric population and adults around the world. For the treatment of many diseases and indications, such as complex regional pain syndrome, low back pain, neck pain and debilitating nerve injuries, the peripheral nerve stimulator is used as a peripheral nerve stimulator, and its growing prevalence is expected to fuel demand and the development of the peripheral nerve stimulator industry.
Peripheral nerve stimulators comprise a small electrical device that is surgically placed next to one of the peripheral nerves. The stimulation provided by this electrical device is recognized as a reliable way of treating chronic pain. Peripheral nerve stimulation devices are especially used in neurological diseases such as epilepsy, Alzheimer’s, Parkinson’s, and others.
Peripheral Nerve Stimulators (PNS) Devices Competitive Assessment
This segment of the Peripheral Nerve Stimulators (PNS) report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Product Type
- By Application
- Major Players in Peripheral Nerve Stimulators (PNS)
- SPRINT (PNS) System: SPR Therapeutics, Inc.
- StimRouter Neuromodulation System: Bioness Inc
Further product details are provided in the report……..
Peripheral Nerve Stimulators (PNS) Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations
This segment of the report provides a detailed list of any commercial activity in the field of Peripheral Nerve Stimulators (PNS) devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
- June 2019, Innovative Health Solutions received FDA clearance for the IB-stim. The IB-stim is the first device cleared for the treatment of irritable bowel syndrome. The device is worn on the ear and stimulates cranial nerve bundles to target areas of the brain involved in processing pain.
Peripheral Nerve Stimulators (PNS): Reimbursement
- US
Further information is provided in the report……..
Report Highlights
- Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
- Peripheral Nerve Stimulators (PNS) - Pipeline Analysis
- Peripheral Nerve Stimulators (PNS) - Unmet Need
- Peripheral Nerve Stimulators (PNS) - Market Dynamics
- Peripheral Nerve Stimulators (PNS) - Future Perspectives and Conclusion
- Peripheral Nerve Stimulators (PNS) - Analyst Views
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of Peripheral Nerve Stimulators (PNS) under development?
- What are market-entry and market expansion strategies in Peripheral Nerve Stimulators (PNS)?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product’s current stage of development, territory and estimated launch date?
- SUNMED Inc
- Stimwave LLC
- SPR Therapeutics LLC
- Medline Industries Inc.
- Boston Scientific Corporation
- Vygon SA
- ElectroCore Inc.
- Enteromedics
- Avanos Pain Management
- NeuroMetrix Inc.
- NeuroSigma Inc.
- B. Braun Melsungen AG.
- IDS Medical Systems
- Medtronic
- St. Jude Medical
- Xavant Technology (Pvt) Ltd
1. KEY INSIGHTS
2. PERIPHERAL NERVE STIMULATORS (PNS): SNAPSHOT
3. PERIPHERAL NERVE STIMULATORS (PNS)
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism
4. PERIPHERAL NERVE STIMULATORS (PNS): COMPETITIVE ASSESSMENT
4.1. Assessment by Product Type
4.2. Assessment by Application
4.2.1. Parkinson's disease
4.2.2. Epilepsy
4.2.3. Alzheimer’s Disease
4.2.4. Depression
4.2.5. Essential Tremors
4.3. Assessment by Company
4.3.1. SPR Therapeutics, Inc.
4.3.1.1. SPRINT (PNS) System: SPR Therapeutics, Inc.
4.3.1.1.1. Product Information
4.3.1.1.2. Research and Development
4.3.1.1.3. Patent Details
4.3.1.1.4. Regulatory Milestone
4.3.2. Bioness Inc
4.3.2.1. StimRouter Neuromodulation System: Bioness Inc
4.3.2.1.1. Product Information
4.3.2.1.2. Research and Development
4.3.2.1.3. Patent Details
4.3.2.1.4. Regulatory Milestone
*More Companies and products would be added in the final report
5. PERIPHERAL NERVE STIMULATORS (PNS): COMPETITIVE BENCHMARKING : BY COMPANY
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations
6. PERIPHERAL NERVE STIMULATORS (PNS) – COMMERCIALIZATION ACTIVITY
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views
7. PERIPHERAL NERVE STIMULATORS (PNS): REGULATORY
7.1. US
7.2. Europe
7.3. Japan
8. PERIPHERAL NERVE STIMULATORS (PNS): REIMBURSEMENT
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study –Japan
9. PERIPHERAL NERVE STIMULATORS (PNS) : MARKET DYNAMICS
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers
10. DELVEINSIGHT’S ANALYTICAL PERSPECTIVE
10.1. PEST Analysis
10.2. Future Growth Perspectives
11. CONCLUSION
12. APPENDIX
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research
13. BIBLIOGRAPHY
14. DELVEINSIGHT CAPABILITIES
15. DISCLAIMER
16. ABOUT DELVEINSIGHT
2. PERIPHERAL NERVE STIMULATORS (PNS): SNAPSHOT
3. PERIPHERAL NERVE STIMULATORS (PNS)
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism
4. PERIPHERAL NERVE STIMULATORS (PNS): COMPETITIVE ASSESSMENT
4.1. Assessment by Product Type
4.2. Assessment by Application
4.2.1. Parkinson's disease
4.2.2. Epilepsy
4.2.3. Alzheimer’s Disease
4.2.4. Depression
4.2.5. Essential Tremors
4.3. Assessment by Company
4.3.1. SPR Therapeutics, Inc.
4.3.1.1. SPRINT (PNS) System: SPR Therapeutics, Inc.
4.3.1.1.1. Product Information
4.3.1.1.2. Research and Development
4.3.1.1.3. Patent Details
4.3.1.1.4. Regulatory Milestone
4.3.2. Bioness Inc
4.3.2.1. StimRouter Neuromodulation System: Bioness Inc
4.3.2.1.1. Product Information
4.3.2.1.2. Research and Development
4.3.2.1.3. Patent Details
4.3.2.1.4. Regulatory Milestone
*More Companies and products would be added in the final report
5. PERIPHERAL NERVE STIMULATORS (PNS): COMPETITIVE BENCHMARKING : BY COMPANY
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations
6. PERIPHERAL NERVE STIMULATORS (PNS) – COMMERCIALIZATION ACTIVITY
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views
7. PERIPHERAL NERVE STIMULATORS (PNS): REGULATORY
7.1. US
7.2. Europe
7.3. Japan
8. PERIPHERAL NERVE STIMULATORS (PNS): REIMBURSEMENT
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study –Japan
9. PERIPHERAL NERVE STIMULATORS (PNS) : MARKET DYNAMICS
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers
10. DELVEINSIGHT’S ANALYTICAL PERSPECTIVE
10.1. PEST Analysis
10.2. Future Growth Perspectives
11. CONCLUSION
12. APPENDIX
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research
13. BIBLIOGRAPHY
14. DELVEINSIGHT CAPABILITIES
15. DISCLAIMER
16. ABOUT DELVEINSIGHT